$491.75
0.180.04%
Pre-Market: Jul 19, 5:21 PM EDT
15 minutes delayed
Comments
Loading...
Vertex Pharmaceuticals
VRTXNASDAQ
Vertex Pharmaceuticals (VRTX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Good
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Quotes, Forecast and News Summary
Vertex Pharmaceuticals Stock (NASDAQ: VRTX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 69.00 / 1.19M |
| Day Range | - - - |
| 52 Wk Range | 340.20 - 496.93 |
| Market Cap | $126.90B |
| P/E Ratio | 31.90 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 66 |
| Short Interest | 1.59% |
| Days to Cover | 2.58 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Vertex Pharmaceuticals, Inc.
Sector
Health Care
Industry
Biotechnology
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule ...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Vertex Pharmaceuticals (VRTX) stock?
You can purchase shares of Vertex Pharmaceuticals (NASDAQ:VRTX) through any online brokerage.
Who are Vertex Pharmaceuticals (VRTX) competitors?
Other companies in Vertex Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Vertex Pharmaceuticals (VRTX) stock?
There is no analysis for Vertex Pharmaceuticals.
What is the forecast for Vertex Pharmaceuticals (VRTX) stock?
Vertex Pharmaceuticals has a consensus price target of $453.08.
Current stock price for Vertex Pharmaceuticals (VRTX)?
The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $491.75 last updated July 19, 2024 at 5:21 PM EDT.
Does Vertex Pharmaceuticals (VRTX) pay a dividend?
There are no upcoming dividends for Vertex Pharmaceuticals.
When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?
Vertex Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Vertex Pharmaceuticals (VRTX) going to split?
There is no upcoming split for Vertex Pharmaceuticals.
What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?
Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.